Cite
HARVARD Citation
Knyazev, O. et al. (n.d.). P243 Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers. Journal of Crohn's and colitis. pp. S286-S287. [Online].